SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alfacell (ACEL)
ACEL 11.54-0.9%Jan 16 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom DuBois who wrote (1407)6/24/1998 6:17:00 PM
From: leighton stallones  Read Replies (2) of 1533
 
Yes Tom I am concerned that the stock is down at unreasonably low
levels. There are many reasons for it and believe it or not most are not
the fault of the company as such. They have been on a very tight budget
not having resources of a major co who normally develop new
drugs. Because of this and not having high profile execs like Amgen,
Supergen they are not having early recognition. I dont believe nor do I
anyone who believes the stock is down because of negative results in
trials.Thats why we are in this situation because of our beliefs. With
a limited amt of $ they can not put out a $15mm release to hype the
stk everytime it needs help like some companies do. They are trying to
finish this project as expeditiously as possible without running out of $.
And yes the negative nonsense is and has been doing damage to this
stock by discouraging new buyers which we need now to turn it up again.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News